DR. BRETT LOUIS PARRA M.D. NPI 1962480624

NPI Details

DR. Brett Louis Parra, M.D. is an urology in Pensacola, FL with 33 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Brett Louis Parra, M.D. NPI is 1962480624. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT
Graduation Year:1993

The provider's business location address is:

4724 N DAVIS HWY
PENSACOLA, FL
ZIP 32503-339
Phone: (850) 696-4000
Fax: (850) 444-7057

The NPI 1962480624 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection, gadobenate dimeglumine (multihance), per ml (HCPCS:A9577)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Injection, triptorelin pamoate, 3.75 mg (HCPCS:J3315)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Blood creatinine level (HCPCS:82565)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Biopsy of prostate gland (HCPCS:55700)
• X-ray of chest, 2 views (HCPCS:71046)
• Simple change of bladder tube (HCPCS:51705)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Ct scan of abdomen before and after contrast (HCPCS:74170)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 1/4/2006 and was last updated on 6/20/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.